The 2024 AAPS National Biotechnology Conference, scheduled for May 13-16, 2024, at the Hilton San Francisco Union Square in California, is set to be a pivotal event in the field of biotechnology. This conference aims to bring together experts and researchers to discuss and explore the latest advancements in biotechnology, focusing on the discovery, formulation, and delivery of new modalities. The event is structured around two main tracks, each encompassing multiple themes that address the forefront of biotechnological research and development. Track 1 delves into the advances in discovery, formulation, and delivery of new modalities, particularly in the biologics market. It invites submissions on a wide range of topics, including multi-specific antibodies, oligonucleotides, proteins, nanobodies, genes, RNA, peptides, cell-free manufactured proteins, vaccines, and various types of cells. The track emphasizes the importance of innovative strategies in addressing unmet medical needs through these modalities.
The conference also features a second track focusing on novel strategies to advance biotherapeutic development, with themes that cover a broad spectrum of current biotechnological challenges and innovations. This includes preformulation and formulation approaches for biologics, drug delivery systems for new modalities and therapies, and the transformative role of AI/ML in drug discovery and development. Additionally, the conference will address the development strategies for novel targeted therapeutic delivery, advances in analytical and bioanalytical platform technology, and high content bioanalysis. These discussions are expected to cover cutting-edge topics such as targeted drug delivery systems, analytical platform technologies, and the integration of artificial intelligence and machine learning in drug development. Overall, the 2024 AAPS National Biotechnology Conference represents a significant gathering for the biotechnology community, offering a platform for the exchange of ideas and fostering collaborations in the pursuit of advancing biotechnological research and applications.